The thesis

The market has taken a bad patch and priced it as permanent decline. Nike is earnings-depressed, not distressed.

• Demand doesn't go away. Everyone needs footwear, and often. Nike is still the category leader across Nike, Jordan and Converse, and brand equity on that scale doesn't evaporate in two weak years.
• Running is a tailwind. On and Hoka took share, but Nike still has the distribution, athletes and R&D to win it back.
• Fashion moves fast. Sneaker culture comes in waves. One strong product cycle could bring it back faster than the market is pricing.
• A self-help turnaround. Elliott Hill is resetting wholesale, clearing inventory and refocusing on sport-led product. That's the classic setup for margin recovery once comps normalise.

Valuation

At $40 Nike trades on 18.6× trailing earnings, half its ten-year average of 37×. The $55 target uses a deliberately conservative 21× on FY27 EPS of $2.57, still below its own history and assuming only a partial recovery. The street's consensus target of $50.66 suggests even cautious analysts think it's oversold, and a 4.2% dividend yield with 20+ years of increases pays you to wait.

What would break it

• The turnaround takes years. JPMorgan sees FY2028 as stabilisation, not growth.
• China stays weak (revenue −17% currency-neutral in Q4).
• Share lost to On and Hoka turns out to be structural.
• More margin pressure from tariffs and discounting.